Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 95,595 | 62,406 | 54,439 | 47,712 | 37,340 |
| Marketable Securities | 105,021 | 128,605 | 145,070 | 154,899 | 25,291 |
| Receivables | 22,098 | 23,258 | 16,841 | 18,266 | 12,617 |
| Inventories | 2,310 | 1,740 | 1,367 | 1,108 | 2,559 |
| TOTAL | $229,968 | $223,007 | $225,115 | $226,337 | $81,573 |
| Non-Current Assets | |||||
| PPE Net | 430 | 489 | 488 | 599 | 422 |
| Investments And Advances | 36,145 | 47,879 | 30,865 | 15,089 | 6,091 |
| Intangibles | 10,806 | 11,122 | 11,438 | 11,754 | 72,078 |
| Other Non-Current Assets | 1,230 | 2,234 | 2,210 | 2,498 | 12,544 |
| TOTAL | $48,611 | $61,724 | $45,001 | $29,940 | $91,135 |
| Total Assets | $278,579 | $284,731 | $270,116 | $256,277 | $172,708 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,688 | 11,598 | 11,072 | 15,842 | 17,819 |
| Other current liabilities | 14,580 | 13,550 | 14,599 | 12,465 | 8,568 |
| TOTAL | $47,028 | $39,277 | $26,112 | $28,832 | $26,976 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 61,928 | 61,310 | 60,692 | 60,090 |
| Other Non-Current Liabilities | 25,747 | 28,869 | 49,529 | 49,523 | 44,619 |
| TOTAL | $25,747 | $90,797 | $110,839 | $110,215 | $104,709 |
| Total Liabilities | $72,775 | $130,074 | $136,951 | $139,047 | $131,685 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,115 | 58,712 | 56,298 | 56,135 | 54,680 |
| Common Shares | 6 | 6 | 6 | 6 | 5 |
| Retained earnings | -384,170 | -422,060 | -434,225 | -433,681 | -508,388 |
| Other shareholders' equity | -1,780 | -747 | -2,399 | -2,411 | -65 |
| TOTAL | $205,804 | $154,657 | $133,165 | $117,230 | $41,023 |
| Total Liabilities And Equity | $278,579 | $284,731 | $270,116 | $256,277 | $172,708 |